Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
89bio (ETNB)
NASDAQ:ETNB
89bio (ETNB) Stock Price & Analysis
434 Followers
ETNB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.00 - $12.95
Previous Close$11.5
Volume437.48K
Average Volume (3M)885.16K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$193.34M
Total Debt (Recent Filing)$20.02M
Price to Earnings (P/E)-2.6
Beta0.89
Next EarningsMar 22, 2023
EPS Estimate-$0.69
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price Target$25.80
EPS (TTM)-4.35
Shares Outstanding46,536,970
R-Squared0.03
Standard Deviation0.28
10 Day Avg. Volume862,205
30 Day Avg. Volume885,159
Price to Book (P/B)3.65
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-10.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside124.35% Upside
Rating ConsensusStrong Buy
Alpha0.00707
Number of Analyst Covering6
89bio News
ETNB FAQ
What was 89bio’s price range in the past 12 months?
89bio lowest stock price was $2.00 and its highest was $12.95 in the past 12 months.
What is 89bio’s market cap?
Currently, no data Available
When is 89bio’s upcoming earnings report date?
89bio’s upcoming earnings report date is Mar 22, 2023 which is in 53 days.
How were 89bio’s earnings last quarter?
89bio released its earnings results on Nov 10, 2022. The company reported -$0.57 earnings per share for the quarter, beating the consensus estimate of -$0.798 by $0.228.
Is 89bio overvalued?
According to Wall Street analysts 89bio’s price is currently Undervalued.
Does 89bio pay dividends?
89bio does not currently pay dividends.
What is 89bio’s EPS estimate?
89bio’s EPS estimate is -$0.69.
How many shares outstanding does 89bio have?
89bio has 46,536,970 shares outstanding.
What happened to 89bio’s price movement after its last earnings report?
89bio reported an EPS of -$0.57 in its last earnings report, beating expectations of -$0.798. Following the earnings report the stock price went up 17.958%.
Which hedge fund is a major shareholder of 89bio?
Among the largest hedge funds holding 89bio’s share is RA Capital Management. It holds 89bio’s shares valued at 45M.
---
89bio Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$25.80
$25.80
Hedge Fund Trend
Decreased
By 506.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.7%
Last 30 Days ▼ 5.0%
Last 30 Days ▼ 5.0%
News Sentiment
Neutral
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
81.67%
12-Months-Change
Fundamentals
Return on Equity
-69.29%
Trailing 12-Months
Asset Growth
19.35%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
89bio
89bio, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases. The company was founded on January 01, 2018 and is headquartered in San Francisco, CA.
---
Lexicon Pharmaceuticals
―
Kodiak Sciences
―
Protagonist Therapeutics
―
Poseida Therapeutics
―
Arbutus Biopharma
―
---